We have examined the ability of the high-mobility group protein 1 (HMG1) to alter binding of the estrogen receptor DNA-binding domain (DBD) to the estrogen response element (ERE). HMG1 dramatically enhanced binding of purified, bacterially expressed DBD to the consensus vitellogenin A2 ERE in a dose-dependent manner. The ability of HMG1 to stabilize the DBD-ERE complex resulted in part from a decrease in the dissociation rate of the DBD from the ERE. Antibody supershift experiments demonstrated that HMG1 was also capable of forming a ternary complex with the ERE-bound DBD in the presence of HMG1-specific antibody. HMG1 did not substantially affect DBD-ERE contacts as assessed by methylation interference assays, nor did it alter the ability of the DBD to induce distortion in ERE-containing DNA fragments. Because HMG1 dramatically enhanced estrogen receptor DBD binding to the ERE, and the DBD is the most highly conserved region among the nuclear receptor superfamily members, HMG1 may function to enhance binding of other nuclear receptors to their respective response elements and act in concert with coactivator proteins to regulate expression of hormone-responsive genes. (Molecular Endocrinology 12: 664-674, 1998)
INTRODUCTION
Steroid hormones play critical roles in development and maintenance of reproductive tissues. Upon binding to the estrogen receptor (ER), estrogenic ligands induce changes in receptor conformation that in turn promote binding of the ER dimer to an estrogen response element (ERE). Because the ER-ERE interaction initiates changes in target gene transcription that result in new protein synthesis, this interaction provides a crucial link in the chain of events that are required for estrogen responsiveness.
It has recently become apparent that association of receptors with activators may be involved in modulating hormone-responsive gene transcription. A number of candidate coactivator proteins have been identified, including SRC1, ERAP 140 and 160, RIP140 and 160, TIF 1, TIF 2, TAFII30, and CBP/p300 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . It is thought that these and other proteins (11, 12) may act in concert with ER to activate transcription. Corepressors, which inhibit steroid hormone receptor-induced transcription, have also been identified (13, 14) . Thus, overall transcription of steroid hormone-responsive genes may be subject to the additive effects of coactivators and corepressors.
The high-mobility group protein 1 (HMG1) is a ubiquitous intracellular protein that binds with low affinity in a sequence-independent manner to single-and double-stranded linear DNA, supercoiled DNA, bent or kinked DNA, and DNA structures such as four-way junctions or cruciform DNA (15) (16) (17) (18) . HMG1 has been conserved evolutionarily in protozoan (19) , yeast (20) , plant (21) , vertebrate (22) , and mammalian (16, 23) cells. This high degree of conservation among such diverse organisms may indicate that HMG1 plays an important role in cell function. In fact, a number of functions have been attributed to HMG1, including DNA bending (24, 25) and loop formation (18) , assembly of nucleoprotein structures (26) , decondensation of chromatin (27) , and transcription activation (28, 29) and repression (30) (31) (32) .
In vitro assays have demonstrated that HMG1 enhances binding of the ER and the progesterone recep-tor (PR) to DNA (33, 34) . However, the receptor regions required for this HMG1-enhanced DNA binding have not been delineated. ER and PR are both members of the nuclear receptor superfamily, which have common structural and functional domains. The most highly conserved region among these nuclear receptor superfamily members is the DNA-binding domain (DBD). It seemed possible that HMG1 might be capable of interacting with nuclear receptor DBDs to enhance receptor binding. To test this hypothesis, we have examined the ability of purified HMG1 to enhance binding of purified ER DBD to ERE-containing DNA fragments. The Xenopus laevis DBD used in these studies encompasses amino acids 171-281, which includes two zinc fingers and an acidic domain from the hinge region (35) , and retains many of the characteristics of the intact ER. The purified DBD is a monomer in solution, binds effectively and with great specificity to consensus and imperfect ERE sequences, and enhances transcription of an estrogen-responsive reporter plasmid in transient transfection assays (36, 37) . In addition, because the DBD is the most highly conserved region of steroid hormone receptors, examination of the interaction of the DBD with target DNA may provide clues as to how steroid hormone receptors exert their effects.
We find that purified HMG1 dramatically enhances binding of the DBD to the ERE. This enhanced binding is in part due to the decreased dissociation rate of the DBD-ERE complex in the presence of HMG1. However, neither the mobility of the DBD-ERE complex nor the DBD contacts with DNA are substantially different in the presence or absence of HMG1. These findings suggest that HMG1 may function to enhance binding of other nuclear receptors to their respective response elements and thereby influence expression of hormone-responsive genes.
RESULTS

The DBD Binds to the ERE as a Homodimer
Binding of bacterially expressed, purified ER DBD to ERE-containing DNA fragments was first examined in the absence of HMG1. Increasing concentrations (0-65 ng) of purified DBD were incubated with 427-bp ERE-containing 32 P-labeled DNA fragments and then fractionated on a nondenaturing acrylamide gel. A single DBD-DNA complex (Fig. 1,4 ) was observed over a range of DBD concentrations. When 10 ng DBD were added to the binding reaction, a faint gel-shifted band was observed. Increasing the amount of DBD in the binding reaction proportionately increased the amount of DBD-DNA complex formed. When 65 ng DBD were added to the binding reaction, which constitutes more than a 250-fold excess of DBD over ERE half-sites, nearly all of the 32 P-labeled DNA fragments were present in the DBD-ERE complex. Two slower migrating bands, which were sometimes present in individual probe preparations, were also observed but were unaffected by DBD addition. The presence of a single gel-shifted band with identical mobility at both low and high DBD concentrations suggested that the DBD bound either as a monomer or as a dimer at all concentrations tested.
To determine whether the DBD was interacting with the consensus ERE as a monomer or as a dimer, deoxyribonuclease I (DNase I) footprinting was carried out using a 281-bp ERE-containing DNA fragment that had been labeled with 32 P on the coding strand. As seen in Fig. 2 , both ERE half-sites were equally protected when the DBD was added to the binding reaction over a wide range of DBD concentrations. Regardless of whether the DBD concentration was low or high, the 5Ј-and 3Ј-half-sites were equally protected. These findings in combination with the gel mobility shift assays, in which only one DBD-ERE complex was observed, demonstrate that the DBD bound only as a homodimer to the ERE and are in agreement with previous gel shift assays using a different, much smaller DNA fragment (37) and with crystal structure studies of the human ER DBD (38, 39) . Interestingly, a hypersensitive site was produced at the 3Ј-but not at the 5Ј-end of the ERE and may reflect changes in DNA structure (40) . DNase I footprinting of the opposite strand also displayed equal protection of both ERE half-sites (data not shown). Increasing amounts of purified DBD (0-65 ng) were incubated with 427 bp 32 P-labeled DNA fragments, each containing a single consensus ERE. The DBD-DNA mixtures were fractionated on a nondenaturing acrylamide gel, which was then dried and subjected to autoradiography. The DBD-ERE complex is indicated (4).
HMG1 Enhances DBD Binding to the ERE
To determine whether HMG1 enhanced ER DBD binding to DNA, a constant amount of purified ER DBD and 32 P-labeled ERE-containing DNA fragments was incubated with increasing amounts of HMG1. When these protein-DNA mixtures were fractionated on an acrylamide gel, the DBD-ERE complex was barely visible with 8 ng purified DBD in the absence of HMG1 (Fig. 3,  0 ng HMG1) . However, addition of purified HMG1 to the binding reaction enhanced the protein-DNA complex formation in a dose-dependent manner. Addition of as little as 10 ng HMG1, which constituted a 1.6-fold excess of DBD monomer over HMG1, enhanced protein-DNA complex formation. However, the exact DBD/HMG1 stoichiometry required for optimal DBD binding is difficult to determine since activity of the purified HMG1 varied somewhat with individual preparations. As seen with the purified DBD alone (Fig. 1) , a single protein-DNA complex, which comigrated with the DBD-ERE complex, was formed when 10-60 ng HMG1 were included in the binding reactions. The enhanced binding observed in the presence of HMG1 was not due to stabilization of the DBD by increased protein concentrations since addition of increasing concentrations of either ovalbumin or BSA failed to elicit a dose-dependent increase in DBD binding (data not shown). However, to ensure that protein concen- The coding strand of a 281-bp DNA fragment was radioactively labeled, combined with increasing amounts of purified DBD, and subjected to DNase I digestion for 2.5 min at room temperature. The cleaved DNA fragments were fractionated on an 8% denaturing acrylamide gel. The gel was dried and subjected to autoradiography. The position of the ERE sequence and a hypersensitive site (*) are indicated to the right of the figure. Increasing amounts of HMG1 (0-60 ng) were incubated with 8 ng purified ER DBD and 32 P-labeled ERE-containing DNA fragments. Ovalbumin was included to maintain protein levels at 2.8 g. Binding reactions were incubated as described in Materials and Methods and then fractionated on a nondenaturing polyacrylamide gel. The gel was dried and subjected to autoradiography. The protein-DNA complex is indicated (4).
trations present in the binding reactions did not influence DBD-DNA complex formation, ovalbumin was added to each of the samples to maintain constant total protein levels while varying the amount of HMG1.
Although HMG1 significantly enhanced the formation of a protein-DNA complex that comigrated with the DBD-DNA complex, it was not clear whether HMG1 was part of this complex. HMG1, which has a molecular mass of 28,000 Da and could feasibly bind to the 32 P-labeled DNA fragments, is nearly identical in size to a DBD dimer formed by two 13,700-Da monomers. To determine which proteins were present in the protein-DNA complexes, antibodies made against the ER DBD and HMG1 were included in the binding reactions. P1A3, a monoclonal antibody made against the purified Xenopus laevis ER DBD (41), supershifted the protein-DNA complexes in the absence (Fig. 4 , lane 2) and in the presence (lane 4) of HMG1, indicating that the DBD was present in both complexes. When the HMG1-specific monoclonal antibody 854E10 was included in the binding reaction, a small portion of the protein-DNA complex was supershifted (lane 5). Higher concentrations of the HMG1 antibody failed to supershift more of the DBD-ERE complex (data not shown). The supershifting of a portion of DBD-ERE complexes suggests that HMG1 was weakly associated with the DBD-ERE complex in solution and that antibody binding stabilized the ternary HMG1-DBD-ERE complex sufficiently so that it could withstand the 3-h electrophoresis period. The HMG1-specific antibody 854E10 has previously demonstrated the ability to supershift a portion of PR-HMG1-DNA complexes (42) . HMG1-DBD-ERE complexes that migrated more slowly than the DBD-ERE complex were not observed in the absence of the HMG1 antibody (lane 3). As an additional control, HMG1 was incubated with ERE-containing DNA fragments in the absence of the DBD, and no supershifted complex was observed (data not shown). Thus, these data suggested that the HMG1 was weakly associated with the DBD-DNA complex.
HMG1 Does Not Alter the DBD Footprint
The DNA fragments used in the gel shift assays were large (427 bp), and the possibility existed that HMG1 might modify the interaction of the DBD with the ERE. To more precisely map the DBD-ERE boundaries, methylation interference experiments were carried out. This procedure utilizes the alkylating agent dimethyl sulfate to chemically methylate the N 7 position of guanine residues. Guanine methylation, in turn, inhibits protein binding and identifies individual nucleotides that are required for protein-DNA interactions.
Purified DBD was incubated with methylated 32 Plabeled DNA fragments in the absence and in the presence of HMG1. Protein-DNA complexes and free DNA were resolved on a nondenaturing gel, electroeluted, cleaved with piperidine, fractionated on a denaturing acrylamide gel, and visualized by autoradiography. As seen in Fig. 5 , only the ERE was involved in the DBD-DNA interaction regardless of whether HMG1 was present. The three guanine residues in the two ERE half-sites (GGTCAcagTGACC) were important for DBD binding (lanes 2 and 3). Fragments that were methylated at these crucial guanine residues were predominantly present in the free probe (lanes 1 and 4). In contrast, methylation of the guanine residue in the 3-bp spacer between the two ERE half-sites disrupted DBD-ERE complex formation somewhat, but was clearly less important than the guanine residues within the ERE half-sites. These findings indicate that HMG1 does not significantly alter the DBD-ERE contacts.
HMG1 Stabilizes DBD-ERE Binding
HMG1 could enhance DBD-ERE complex formation by increasing the association rate, decreasing the dissociation rate, or a combination of these two events. Purified DBD was incubated with 32 P-labeled ERE-containing DNA fragments in the absence (lanes 1 and 2) or in the presence of HMG1 (lanes 3-5). DBD-specific (␣DBD) or HMG1-specific (␣HMG1) monoclonal antibodies were included in the binding reactions as indicated. Ovalbumin was added to lanes without antibody to maintain total protein concentration. The DBD-DNA mixtures were fractionated on a nondenaturing acrylamide gel. The gel was dried and subjected to autoradiography.
HMG1 Enhances ER DBD binding
To determine whether HMG1 influenced the association rate of the DBD with the ERE, purified DBD was incubated with 32 P-labeled ERE-containing DNA fragments in the absence and in the presence of HMG1 for 0.5-10 min at 4 C and then loaded onto a running acrylamide gel. The DBD-ERE association occurred very rapidly in the absence and in the presence of HMG1 (Fig. 6 ). Despite the fact that the reactions were carried out at 4 C in the presence of 15% glycerol to slow the association, maximal binding was achieved at the earliest timepoint measured (0.5 min). Because the DBD-ERE association was so rapid, we were unable to determine whether HMG1 affected the DBD-ERE association rate. It is clear, however, that the DBD associates very rapidly with the ERE in the absence and in the presence of HMG1 and that maximal binding is achieved by 0.5 min.
To determine whether HMG1 influenced the dissociation rate of the DBD from the ERE, purified DBD was incubated with ERE-containing DNA fragments in the absence and in the presence of HMG1. An excess of unlabeled ERE (300 ng) was added to the binding reaction after a 10-min incubation and 20-l aliquots were removed at specified times and loaded directly P-labeled ERE-containing DNA fragments were combined with purified DBD alone or with DBD plus 75 ng HMG1 and incubated at 4 C. Aliquots were removed 0.5, 1, 2, 5, and 10 min after DBD addition and loaded directly onto a running acrylamide gel. The gel was dried and subjected to autoradiography.
100 ng purified DBD (lanes 1 and 2) or 50 ng purified DBD plus 250 ng purified HMG1 (lanes 3 and 4) and fractionated on a nondenaturing acrylamide gel. The complexed (C) and free (F) DNA from each lane were electroeluted, precipitated, cleaved with piperidine, and fractionated on a sequencing gel. The gel was dried and subjected to autoradiography. The sequence and position of the ERE are indicated. onto a running acrylamide gel. In the absence of HMG1, the DBD dissociated very rapidly from the ERE, so that 2 min after addition of the unlabeled ERE the DBD-ERE complex was nearly undetectable (Fig.  7) . Addition of 75 ng HMG1 consistently slowed dissociation of the DBD from the ERE when the unlabeled ERE oligo was present, so that DBD-ERE complexes were still detectable 30 min after addition of the unlabeled ERE. In the absence of unlabeled ERE oligo, the DBD-DNA complex remained stable for the 30-min incubation period (data not shown). Thus, HMG1 helped to stabilize the DBD-ERE interaction by decreasing the dissociation rate of the DBD from the ERE. Specific DBD/HMG1 ratios may be needed to stabilize the DBD-ERE interaction since 50 ng HMG1 failed to stabilize and 100 ng did not further stabilize DBD-ERE complex formation (data not shown). However, due to batch-to-batch variations in HMG1 activ- P-labeled ERE-containing DNA fragments were combined with purified DBD alone or with DBD plus 75 ng HMG1 and incubated for 10 min at 4 C. A 20-l aliquot was removed and loaded directly onto a running acrylamide gel, and 300 ng of a 30-bp oligo containing the ERE were immediately added to the incubation. Aliquots (20 l) were removed 0.25-30 min after addition of the ERE oligo and loaded onto a running acrylamide gel. The gel was dried and subjected to autoradiography. C, Results from six (DBD alone) or seven (DBD and HMG1) independent experiments were combined, and values are presented as the mean Ϯ SE. Several error bars are quite small and are not visible. ity, the DBD/HMG1 ratio required for DBD stabilization must be empirically determined for each HMG1 preparation.
HMG1 Does Not Affect the Ability of the DBD to Distort DNA
We have previously demonstrated that the DBD induces distortion in ERE-containing DNA fragments (43) (44) (45) . Since HMG1 recognizes bent DNA structures and induces DNA bending (46, 47) , it seemed plausible that HMG1 might affect the ability of the DBD to distort DNA. Therefore, circular permutation analysis was carried out using a series of DNA fragments, each of which contained a consensus ERE at varying positions. Either 25 ng DBD alone or 8 ng DBD plus 70 ng HMG1 were incubated with 32 P-labeled ERE-containing DNA fragments. As evidenced by the differential migration of the DBD-DNA complexes, the DBD induced distortion in ERE-containing DNA fragments in the absence and in the presence of HMG1 (Fig. 8) . DNA-bending standards (48) were used to determine that the degree of distortion induced by DBD binding was 33 o in the presence and in the absence of HMG1. These studies are in good agreement with earlier studies examining DBD-induced distortion in DNA fragments (43) and demonstrate that HMG1 does not alter the degree of distortion induced by DBD binding.
DISCUSSION
A number of studies have reported that purified steroid hormone receptors bind poorly to their recognition sequences when compared with receptors associated with other cellular proteins. The fact that addition of crude cellular or purified proteins restores the ability of the purified receptors to bind to DNA (12, 34, 49) suggests that nuclear receptors do not function in isolation, but that they require the participation of other cellular proteins to efficiently bind to DNA. One protein that has demonstrated the ability to enhance binding of ER and PR to their respective response elements is HMG1 (33, 34, 42) . In this work we demonstrated that incremental addition of HMG1 induced a dose-dependent increase in binding of the ER DBD to the ERE.
Three guanine residues were particularly important for DBD-ERE binding in the presence and in the absence of HMG1. Crystal structure studies of the human ER DBD have demonstrated that these guanines (GGTCAcagTGACC) form hydrogen bonds with lysine and arginine residues in the DBD recognition helix (38) . Since the zinc finger regions of the human and Xenopus laevis ER DBDs are completely conserved, except for a single serine residue at position 184 in the first finger of the Xenopus DBD, one would anticipate that protein-DNA contacts formed when the Xenopus and human ER DBDs bind to the ERE would be very similar. Our methylation interference experiments suggest that the crystal structure for the human ER can be used as a template to predict the position of the amino acids in the Xenopus ER DBD. Although the three highly conserved guanine residues present in the ERE half-sites were extremely important in the DBD-ERE interaction, the guanine residue in the 3-bp spacer between the two ERE half-sites was significantly less important. This might be expected since the spacer region varies significantly with individual ERE sequences.
Interestingly, HMG1 enhanced binding of the DBD to ERE-containing DNA fragments but did not alter the mobility of the protein-DNA complexes. These findings are reminiscent of studies carried out with PR and the HOXD9 homeodomain protein, in which HMG1 enhanced binding but did not alter the mobility of the protein-DNA complex in gel mobility shift experiments (34, 42, 50) . HMG1 association with HOXD9-DNA complex was detected by methods that did not require the extended time periods required for gel mobility shift assays (50) . Likewise, a ternary PR-DNA-HMG1 complex was detected in antibody supershift experiments when an HMG1-specific antibody was present (42) . Taken together, these studies imply that HMG1 may assist in transcription factor binding and participate in formation of a ternary complex, but that it is weakly associated with the protein-DNA complex. This view is supported by our antibody supershift experiments in which an HMG1-specific antibody super- D) . These fragments were incubated with 25 ng DBD or 8 ng DBD and 70 ng HMG1. The DBD-DNA mixtures were fractionated on a nondenaturing acrylamide gel. The gel was dried and subjected to autoradiography. DNA fragments containing 36°and 54°i ntrinsic bending sequences were also included on the gel.
shifted a portion of the DBD-DNA complex. Since no supershifted complex was observed in the absence of DBD, this supershifted complex must represent a ternary DBD-HMG1-DNA complex that was stabilized by antibody binding. In the absence of antibody, the ternary complex is most likely unstable during the prolonged electrophoretic process. The ability of an antibody to stabilize this ternary complex is similar to the stabilization of the ER-ERE complex by ER-specific antibody (51).
Travers et al. (52) have hypothesized that HMG1 may serve as a DNA "chaperone" to enhance conformational changes in DNA and facilitate the assembly of nucleoprotein complexes. In this capacity HMG1 could interact directly with DNA to enhance DBD-ERE interaction by binding and distorting the ERE into a more thermodynamically favorable conformation so that subsequent binding by the DBD would be facilitated. In support of this idea, one group has reported that HMG1 enhances binding of the full-length ER to the ERE only when HMG1 is present before addition of the receptor (33) . Although our data demonstrate that HMG1 has a profound effect on the ability of the DBD to bind to the ERE when HMG1 is the last component added to the binding reaction, we did not find that the order of addition substantially affected the ability of HMG1 to enhance DBD binding. These findings do not necessarily rule out the possibility that HMG1 assists DBD binding by inducing conformational changes in DNA structure. In fact, we have previously demonstrated that local DNA structure does influence DBD binding to the ERE. When the ERE is bent in a direction that opposes the ER-induced DNA bend (45), the DBD-ERE complex is less stable than when the ERE is bent in the same direction as the ER-induced DNA bend (53). Thus, it is possible that HMG1 may enhance binding of the ER DBD and the full-length ER to the ERE by prebending the DNA.
Like HMG1, the DBD binds and induces distortion in DNA structure (24, 26, 44, 45) . Since the 33°DBD-induced distortion angle was not altered by the presence of HMG1, our data support the idea that the DBD, but not HMG1, is strongly associated with the ERE-containing DNA fragments. Our findings with the ER DBD are also consistent with previous studies in which HMG1 enhanced binding of the intact PR to DNA, but did not alter the magnitude of the PRinduced DNA bending (42) .
HMG1 stimulates transcription activation (28, 29) , transcription repression (30), decondensation of chromatin (27) , and nucleosome assembly (26) . A common feature of these processes is the assembly of higher order nucleoprotein complexes. Since endogenous hormone-responsive genes contain multiple transcription factor-binding sites that are separated by varying distances, HMG1 may play a role in formation of the higher order nucleoprotein complexes by promoting DNA flexibility and transcription factor binding. This hypothesis is consistent with a recent study by Verrier et al. (33) , which demonstrated that although HMG1 alone was unable to enhance ER-mediated transcription activation, HMG1 in combination with TAFII30 activates transcription. Thus, HMG1 may be necessary, but not sufficient, for transcription activation and may require the participation of other transcription factors to bring about its effects.
Like histone H1, HMG1 binds to linker DNA located between nucleosomes and is thought to play a role in organizing chromatin structure by positioning nucleosomes or looping DNA (22, 31) . Although nucleosome repositioning has not been reported for estrogenresponsive genes, it is a critical step in the regulation of glucocorticoid-responsive genes (54, 55) . Even if repositioning of nucleosomes is not required for transcription activation of estrogen-responsive genes, HMG1-induced DNA looping could help provide the chromatin structure required for transactivation of genes. DNA looping, which could be assisted by HMG1, has been documented in the estrogen-responsive PRL (56) and vitellogenin (57) genes. Thus, the ability of HMG1 to bend DNA, combined with the ability of the receptor to recognize specific DNA sequences, could work in concert to provide the geometry and sequence specificity required for transcription of hormone-responsive genes.
We have demonstrated that the only ER region needed for HMG1-enhanced binding to the ERE is the DBD. It is interesting to note that the only region of the HOXD9 homeodomain protein required for HMG1-enhanced binding is the DBD (50) . Given the high degree of conservation in DBD amino acid sequence among the steroid receptor superfamily members, one might predict that the binding of other steroid hormone receptors would also be enhanced by the presence of HMG1 and that HMG1 may be involved in regulating transcription of a number of hormone-responsive genes.
MATERIALS AND METHODS
Isolation of Purified Proteins
HMG1 was purified from calf thymus as previously described (34) . The Xenopus laevis ER DBD was expressed in BL21(DE3) plys S cells (58) and purified using BioRex 70 (Bio-Rad Laboratories, Hercules, CA) and phosphocellulose chromatography as described previously (37) . Purified proteins were stored at Ϫ70 C and thawed on ice before use.
Plasmids and Preparation of 32 P-Labeled DNA Fragments
The construction of the circular permutation vectors ERE Bend I (43) and ERE Bend III were previously described (59) .
For gel mobility shift assays, ERE Bend I (43) was digested with EcoRI, HindIII, EcoRV, NheI, or BamHI to produce 427-bp DNA fragments containing a consensus ERE at the 3Ј-end, at an intermediate 3Ј-position, in the middle, at an intermediate 5Ј-position, or at the 5Ј-end of the DNA fragment, respectively. The DNA fragments were end-labeled with ␥[ 32 P]ATP as previously described (37, 43) . DNA-HMG1 Enhances ER DBD bindingbending standards, kindly provided by A. Landy (48) , were digested and labeled as described (43) .
For DNase I and methylation interference footprinting, the circular permutation plasmid B3consERE (59) was digested with EcoRV and HindIII to produce 281-bp ERE-containing DNA fragments, which were fractionated on a 5% acrylamide gel, cut out of the gel, and electroeluted. The purified endlabeled DNA fragments were filled in with ␣[ 
Gel Mobility Shift Assays
Purified DBD was combined with 5000-10,000 cpm 32 P-labeled ERE-containing DNA fragments and 50 ng poly(dI-dC) in binding reaction buffer (15 mM Tris, pH 7.9, 0.2 mM EDTA, 80 mM KCl, 4 mM dithiothreitol, and 10% glycerol) to a final volume of 20 l. Varying amounts of ovalbumin were included in each binding reaction to maintain total protein levels at 2.8 g. HMG1 was added to the binding reaction last. Protein-DNA mixtures were incubated for 10 min on ice, followed by 5 min at room temperature, and then fractionated on a low ionic strength, nondenaturing polyacrylamide gel (60) . For antibody supershift experiments, the monoclonal antibody P1A3, which was made against the purified Xenopus laevis ER DBD (41), or monoclonal antibody 854E10 (42) , which was made against purified calf thymus HMG1, was added to the incubation just before addition of the HMG1. For association and dissociation rate determinations, glycerol concentrations were increased to 15% and all reactions were maintained at 4 C. To determine the association rate, 120-l samples were incubated at 4 C and 20-l aliquots were removed and loaded onto a running gel 0.5 to 10 min after DBD addition. To determine the dissociation rate, samples were maintained at 4 C for 10 min. After a 20-l aliquot was removed and loaded onto a running gel (time 0), 300 ng of a 30-bp annealed oligo containing the ERE was immediately added. Twenty-microliter aliquots were removed and loaded onto a running gel 0.25-30 min after addition of the ERE oligo. All gels were run at 4 C with buffer recirculation, dried, and subjected to autoradiography. For circular permutation experiments, DNA bending standards (48) were included on gels to determine the magnitude of the DBD-induced DNA bend as previously described (43) . Relative mobilities of DNA bending standards, free DNA, and protein-DNA complexes were determined using a Molecular Dynamics PhosphorImager and Image Quant software (Molecular Dynamics, Sunnyvale, CA).
DNase I Footprinting
DNase I footprinting was carried out essentially as described (41) . Briefly, EcoRV/HindIII-digested, end-labeled DNA fragments (30,000 cpm) containing the consensus ERE were combined with 0-1 g of purified DBD in binding reaction buffer with 1.25 mM MgCl 2 and 0.5 mM CaCl 2 . Ovalbumin was included so that the total protein concentration in each sample was maintained at 1 g. The binding reaction was incubated for 15 min at room temperature. 0.5 U of RQ1 ribonuclease-Free DNase I (Promega, Madison, WI) was added to each sample and incubated at room temperature for 2.5 min. DNase I digestion was terminated with stop solution (200 mM NaCl, 1% SDS, and 30 mM EDTA). The DNA was extracted with phenol-chloroform, precipitated, washed twice with 70% ethanol, dried, and resuspended in 8 l of loading buffer (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol). Samples were incubated at 90 C for 1.5 min before loading onto a denaturing 8% polyacrylamide gel. The gel was electrophoresed, dried, and exposed to x-ray film with an intensifying screen for 12-16 h at Ϫ70 C.
Methylation Interference
Methylation interference assays were carried out essentially as described (41) . Briefly, the EcoRV/HindIII-digested, endlabeled DNA fragments (2,000,000 cpm) were methylated for 5 min with 0.5% dimethyl sulfate in a reaction buffer containing 50 mM sodium cacodylate, pH 8.0, and 1 mM EDTA (211 l final volume). The reaction was terminated with 50 l stop buffer (1.5 M sodium acetate, pH 7.0, 1 M ␤-mercaptoethanol, and 100 g/ml tRNA) and chilled ethanol, precipitated twice, and resuspended in TE. Approximately 500,000 cpm methylated probe was combined with binding reaction buffer, 125 ng poly(dI-dC), and either 100 ng purified DBD or 50 ng purified DBD plus 250 ng purified HMG1. The 50-l reaction mixture was fractionated on an 8% polyacrylamide nondenaturing gel as described above. The wet gels were exposed to film for 2-6 h to detect free probe and protein-DNA complexes. Free and complexed DNA were excised from the gel, isolated by electroelution, and precipitated. The modified DNA was cleaved for 30 min with 10% piperidine at 90 C. After evaporation of the piperidine solution, the DNA was resuspended in 30 l water, lyophilized, resuspended in 20 l water, and lyophilized. The DNA fragments were resuspended in loading buffer, incubated at 90 C for 1.5 min, and electrophoresed on an 8% denaturing gel 3 h at constant power (30 watts). The gel was dried and visualized by autoradiography.
